Antidepressant-like effects of Bupleuri Radix extract

European Journal of Integrative Medicine

Volumn 4, Issue 4, 2012, Pages

  Seo, Mi Kyoung ^a   Song, Jae Chun ^a   Lee, Sun Jung ^a   Koo, Kyung Ah ^c   Park, Yong Ki ^d   Lee, Jung Goo ^a,b   Park, Sung Woo ^a   Kim, Young Hoon ^a,b  

^a Inje University   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c University of the Sciences in Philadelphia   (United States)

^d Dongguk University   (South Korea)

Author keywords

Antidepressant effect; Brain derived neurotrophic factor; Bupleuri Radix; Forced swimming test; Glycogen synthase kinase 3

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; BUPLEURUM ROOT EXTRACT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE 2 RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN KINASE B; SEROTONIN 1A RECEPTOR; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG EFFECT; FORCED SWIMMING TEST; HUMAN; HUMAN CELL; MALE; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84872370615     PISSN: 18763820     EISSN: 18763839     Source Type: Journal    
DOI: 10.1016/j.eujim.2012.07.979     Document Type: Article

References (44)

1. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Archives of General Psychiatry 1994, 51:8-19.
2. An L., Zhang Y.Z., Yu N.J., Liu X.M., Zhao N., Yuan L., et al. Role for serotonin in the antidepressant-like effect of a flavonoid extract of Xiaobuxin-Tang. Pharmacology Biochemistry and Behavior 2008, 89:572-580.
3. Mantani N., Hisanaga A., Kogure T., Kita T., Shimada Y., Terasawa K. Four cases of panic disorder successfully treated with Kampo (Japanese herbal) medicines: Kami-shoyo-san and Hange-koboku-to. Psychiatry and Clinical Neurosciences 2002, 56:617-620.
4. Yamada K., Kanba S. Herbal medicine (Kami-shoyo-san) in the treatment of premenstrual dysphoric disorder. Journal of Clinical Psychopharmacology 2002, 22:442.
5. Park S.W., Kim Y.K., Lee J.G., Kim S.H., Kim J.M., Yoon J.S., et al. Antidepressant-like effects of the traditional Chinese medicine Kami-shoyo-san in rats. Psychiatry and Clinical Neurosciences 2007, 61:401-406.
6. Lee B., Shim I., Lee H., Hahm D.H. Effect of Bupleurum falcatum on the stress-induced impairment of spatial working memory in rats. Biological and Pharmaceutical Bulletin 2009, 32:1392-1398.
7. Kim S.H., Han J., Seog D.H., Chung J.Y., Kim N., Park H.Y., et al. Antidepressant effect of Chaihu-Shugan-San extract and its constituents in rat models of depression. Life Sciences 2005, 76:1297-1306.
8. Liao J.F., Jan Y.M., Huang S.Y., Wang H.H., Yu L.L., Chen C.F. Evaluation with receptor binding assay on the water extracts of ten CNS-active Chinese herbal drugs. Proceedings of the National Science Council, Republic of China. Part B, Life Sciences 1995, 19:151-158.
9. Wing Y.K. Herbal treatment of insomnia. Hong Kong Medical Journal 2001, 7:392-402.
10. Duman R.S., Malberg J., Nakagawa S., D'Sa C. Neuronal plasticity and survival in mood disorders. Biological Psychiatry 2000, 48:732-739.
11. Nibuya M., Nestler E.J., Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. Journal of Neuroscience 1996, 16:2365-2372.
12. Castrén E. Neurotrophic effects of antidepressant drugs. Current Opinion in Pharmacology 2004, 4:58-64.
13. Castrén E., Rantamäki T. The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Developmental Neurobiology 2010, 70:289-297.
14. Grimes C.A., Jope R.S. The multifaceted roles of glycogen synthase kinase 3β in cellular signaling. Progress in Neurobiology 2001, 65:391-426.
15. Nakagawara A., Azar C.G., Scavarda N.J., Brodeur G.M. Expression and function of TRK-B and BDNF in human neuroblastomas. Molecular and Cellular Biology 1994, 14:759-767.
16. Li Z., Tan F., Thiele C.J. Inactivation of glycogen synthase kinase-3β contributes to brain-derived neutrophic factor/TrkB-induced resistance to chemotherapy in neuroblastoma cells. Molecular Cancer Therapeutics 2007, 6:3113-3121.
17. Gould T.D., Zarate C.A., Manji H.K. Glycogen synthase kinase-3: a target for novel bipolar disorder treatments. Journal of Clinical Psychiatry 2004, 65:10-21.
18. Jope R.S., Roh M.S. Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. Current Drug Targets 2006, 7:1421-1434.
19. Gould T.D., Einat H., Bhat R., Manji H.K. AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. International Journal of Neuropsychopharmacology 2004, 7:387-390.
20. Kaidanovich-Beilin O., Milman A., Weizman A., Pick C.G., Eldar-Finkelman H. Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β-catenin in mouse hippocampus. Biological Psychiatry 2004, 55:781-784.
21. Rosa A.O., Kaster M.P., Binfaré R.W., Morales S., Martín-Aparicio E., Navarro-Rico M.L., et al. Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2008, 32:1549-1556.
22. Borsini F., Bendotti C., Velkov V., Rech R., Samanin R. Immobility test: effects of 5-hydroxytryptaminergic drugs and role of catecholamines in the activity of some antidepressants. Journal of Pharmacy and Pharmacology 1981, 33:33-37.
23. Porsolt R.D., LePichon M., Jalfre M. Depression: new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
24. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioral despair in rats: a new model sensitive to antidepressant treatment. European Journal of Pharmacology 1978, 47:379-391.
25. Mizoguchi K., Yuzurihara M., Ishige A., Aburada M., Tabira T. Saiko-ka-ryukotsu-borei-to, a herbal medicine, ameliorates chronic stress-induced depressive state in rotarod performance. Pharmacology Biochemistry and Behavior 2003, 75:419-425.
26. Gao X., Zheng X., Li Z., Zhou Y., Sun H., Zhang L., et al. Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry. Journal of Ethnopharmacology 2011, 137:690-699.
27. Zhou Y., Lu L., Li Z., Gao X., Tian J., Zhang L., et al. Antidepressant-like effects of the fractions of Xiaoyaosan on rat model of chronic unpredictable mild stress. Journal of Ethnopharmacology 2011, 137:236-244.
28. Nemeroff C.B., Owens M.J. Treatment of mood disorders. Nature Neuroscience 2002, 5(suppl.1):1068-1070.
29. D'Sa C., Duman R.S. Antidepressants and neuroplasticity. Bipolar Disorders 2002, 4:183-194.
30. Duman R.S., Nakagawa S., Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 2001, 25:836-844.
31. O'Leary O.F., Wu X., Castren E. Chronic fluoxetine treatment increases expression of synaptic proteins in the hippocampus of the ovariectomized rat: role of BDNF signalling. Psychoneuroendocrinology 2009, 34:367-381.
32. Gould T.D., Einat H., O'Donnell K.C., Picchini A.M., Schloesser R.J., Manji H.K. β-Catenin overexpression in the mouse brain phenocopies lithium-sensitive behaviors. Neuropsychopharmacology 2007, 32:2173-2183.
33. Roh M.S., Kang U.G., Shin S.Y., Lee Y.H., Jung H.Y., Juhnn Y.S., et al. Biphasic changes in the Ser-9 phosphorylation of glycogen synthase kinase-3β after electroconvulsive shock in the rat brain. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2003, 27:1-5.
34. Li X., Zhu W., Roh M.S., Friedman A.B., Rosborough K., Jope R.S. In vivo regulation of glycogen synthase kinase-3β (GSK-3β) by serotonergic activity in mouse brain. Neuropsychopharmacology 2004, 29:1426-1431.
35. Yu X., Malenka R.C. β-Catenin is critical for dendritic morphogenesis. Nature Neuroscience 2003, 6:1169-1177.
36. Logan C.Y., Nusse R. The Wnt signaling pathway in development and disease. Annual Review of Cell and Developmental Biology 2004, 20:781-810.
37. Jope R.S., Bijur G.N. Mood stabilizers, glycogen synthase kinase-3β and cell survival. Molecular Psychiatry 2002, 7(suppl.1):S35-S45.
38. Beaulieu J.M., Marion S., Rodriguiz R.M., Medvedev I.O., Sotnikova T.D., Ghisi V., et al. A β-arrestin 2 signaling complex mediates lithium action on behavior. Cell 2008, 132:125-136.
39. Beaulieu J.M., Sotnikova T.D., Marion S., Lefkowitz R.J., Gainetdinov R.R., Caron M.G. An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 2005, 122:261-273.
40. Hsu Y.L., Kuo P.L., Lin C.C. The proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells. Life Sciences 2004, 75:1231-1242.
41. Hsu Y.L., Kuo P.L., Weng T.C., Yen M.H., Chiang L.C., Lin C.C. The antiproliferative activity of saponin-enriched fraction from Bupleurum Kaoi is through Fas-dependent apoptotic pathway in human non-small cell lung cancer A549 cells. Biological and Pharmaceutical Bulletin 2004, 27:1112-1115.
42. Biedler J.L., Roffler-Tarlov S., Schachner M., Freedman L.S. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Research 1978, 38:3751-3757.
43. Farooqui S.M. Induction of adenylate cyclase sensitive dopamine D2-receptors in retinoic acid induced differentiated human neuroblastoma SHSY-5Y cells. Life Sciences 1994, 55:1887-1893.
44. Yaniv S.P., Lucki A., Klein E., Ben-Shachar D. Dexamethasone enhances the norepinephrine-induced ERK/MAPK intracellular pathway possibly via dysregulation of the alpha2-adrenergic receptor: implications for antidepressant drug mechanism of action. European Journal of Cell Biology 2010, 89:712-722.